Quantcast

Cornhusker State News

Wednesday, November 5, 2025

FDA conducted second highest number of inspections on Drugs companies in Nebraska during Q3

Webp wpqolpnrcij8e8mt9jfg90exrory

Mark Raza Principal Deputy Chief Counsel - FDA | Official Website

Mark Raza Principal Deputy Chief Counsel - FDA | Official Website

In the third quarter of 2025, two Drugs companies received two FDA inspections in Nebraska, according to the U.S. Food and Drug Administration (FDA).

This was the second highest number of inspections per type of company made by the FDA in Nebraska, equalling 28.6% of all inspections in the third quarter of 2025.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

FDA Inspections in Nebraska During Q3
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Drug Quality Assurance2
Foodborne Biological Hazards3
Human Cellular, Tissue, and Gene Therapies1
Monitoring of Marketed Animal Drugs, Feed, and Devices1
Information in this story was obtained from the U.S. Food and Drug Administration. The source data can be found here.

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS